drugset / Trial / NCT02075632

Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream

NCT02075632 ↗

Phase 2 Completed 310 enrolled GlaxoSmithKline
NaSingle-groupOpen-labelTreatment

Summary

This is a multi-center, open-label study to evaluate whether participants follow the duration of use instructions for short-term use of alclometasone dipropionate in a population of participants with itchy skin conditions who would use OTC treatments for relief. The study population will be composed of two different cohorts: chronic condition sufferers (eczema or psoriasis) and participants who suffer from occasional itchy skin experiences (such as poison ivy, oak, sumac, insect bites, or skin irritations due to jewelry, cosmetics, detergents, or soaps) where an anti-itch medication would be used.

Timeline

Start
2006-09
Primary completion
2006-11
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Alclometasone dipropionate Small molecule — Topical